Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Cancer
    • Prostate cancer rising...

    Prostate cancer rising by 2.5 % a year in India: Experts

    Written by supriya kashyap kashyap Published On 2016-12-20T11:20:01+05:30  |  Updated On 20 Dec 2016 11:20 AM IST
    Prostate cancer rising by 2.5 % a year in India: Experts

    Mumbai : Prostate cancer the second most common cancer among the residents of Delhi, Thiruvananthapuram, Kolkata and Pune is increasing at the rate of 2.5 per cent per year, health experts said.


    According to the doctors, late detection and unawareness of the disease is the sole reason that prostrate cancer has affected a total of 1.7 million people around the globe, with 2,88,000 cases in India alone.


    Also, citing the rise of benign prostatic hyperplasia (BPH), another serious prostrate problem, the doctors have urged persons above 40 to undergo monthly checkups.


    "In Mumbai the incidence of prostate cancer is rising as seen in last three decades with the result that it has become one of the most common cause of cancer deaths in males. Every year around 300 new cases of prostate cancer are reported and of them 25-30 per cent cases belong to early stage," Jagdeesh N. Kulkarni, Professor of Uro-Oncology at the Asian Cancer Institute, told IANS.


    Emphasising the fact that the early stage of prostate cancer has high potential for cure either by radical prostatectomy or non-surgical treatment like radiation therapy, Kulkarni said: "Robot assisted laparoscopic prostatectomy (RALP) is the latest advancement to remove cancerous prostate in the field of urology and it brings several advantages as compared to the traditional open surgery."


    "Moreover, minimally invasive technique is less traumatic and enhances outcomes and patient recovery. Importantly, minimal invasive technique helps patients with early post-operative recovery and early resumption of duties," said Kulkarni.


    The prostate is a small but an important gland (organ) in the male reproductive system. It surrounds the urethra, the tube that carries urine from the bladder to the outside.


    As the prostate gland enlarges it tightens around the urethra, almost squeezing it like pinching a straw. This in turn may cause urinary symptoms. This condition is known as benign prostatic hyperplasia or BPH.


    Health experts have also emphasised on the rising cases of BPH and said that while prostrate cancer can be treated with surgery and radiation therapy, depending on the stage of the disease, BPH can be treated with medicines. However, in case of complications surgery may be needed.


    V.Srinivas, a city based expert on prostrate cancer, said men above the age of 50 should be encouraged and counselled to undergo digital rectal examination (DRE) and prostate specific antigen study (PSA) to detect prostate cancer in its early stage.


    "It is also very important for the patient to develop an extensive communication with the doctors and the patient's PSA screening. Organising BPH camps may facilitate in early detection and should be encouraged," said Ramesh Mahajan, Consultant Urologist at Fortis Hospital.


    "The incidence of BPH rises with aging. By 60 years of age, more than 50 per cent of men develop BPH and by age of 85 years, nearly 90 per cent of men will have BPH," said Mahajan.


    According to Mahajan, a simple blood test and medical check up will diagnose BPH and to detect PSA (Prostate Specific Antigen) level, which is an enzyme secreted by the prostate, may help to distinguish between BPH and prostate cancer.

    benign prostatic hyperplasiaBPHcancerdigital rectal examinationDr Jagdeesh N KulkarniDr Ramesh MahajanDREFortis hospitalprostate cancerRALP
    Source : IANS

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok